Vinorelbine, a plant-derived chemotherapy agent, holds immense power in the fight against cancer. Its effectiveness in treating various malignancies, including non-small cell lung cancer and breast cancer, has propelled it to prominence in the global oncology market. Understanding who buys vinorelbine and why is crucial for manufacturers, distributors, and any stakeholder involved in this life-saving medication’s journey. Top Global Buyers of Vinorelbine: Hospitals and cancer centers: These institutions represent the primary point of contact for patients receiving vinorelbine treatment. Large hospital networks and specialized cancer centers are significant buyers. Government agencies: National healthcare systems and public health departments procure vinorelbine for public hospitals and treatment programs, particularly in countries with…